260 related articles for article (PubMed ID: 37511303)
1. Gender Differences and miRNAs Expression in Cancer: Implications on Prognosis and Susceptibility.
Caserta S; Gangemi S; Murdaca G; Allegra A
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511303
[TBL] [Abstract][Full Text] [Related]
2. MEG3-derived miR-493-5p overcomes the oncogenic feature of IGF2-miR-483 loss of imprinting in hepatic cancer cells.
Gailhouste L; Liew LC; Yasukawa K; Hatada I; Tanaka Y; Kato T; Nakagama H; Ochiya T
Cell Death Dis; 2019 Jul; 10(8):553. PubMed ID: 31320614
[TBL] [Abstract][Full Text] [Related]
3. Estradiol induces apoptosis via activation of miRNA-23a and p53: implication for gender difference in liver cancer development.
Huang FY; Wong DK; Seto WK; Lai CL; Yuen MF
Oncotarget; 2015 Oct; 6(33):34941-52. PubMed ID: 26439986
[TBL] [Abstract][Full Text] [Related]
4. MiRNA expression profiles reveal the involvement of miR-26a, miR-548l and miR-34a in hepatocellular carcinoma progression through regulation of ST3GAL5.
Cai H; Zhou H; Miao Y; Li N; Zhao L; Jia L
Lab Invest; 2017 May; 97(5):530-542. PubMed ID: 28218742
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.
Liu WH; Yeh SH; Lu CC; Yu SL; Chen HY; Lin CY; Chen DS; Chen PJ
Gastroenterology; 2009 Feb; 136(2):683-93. PubMed ID: 19027010
[TBL] [Abstract][Full Text] [Related]
6. Gene expression network regulated by DNA methylation and microRNA during microcystin-leucine arginine induced malignant transformation in human hepatocyte L02 cells.
Chen HQ; Zhao J; Li Y; He LX; Huang YJ; Shu WQ; Cao J; Liu WB; Liu JY
Toxicol Lett; 2018 Jun; 289():42-53. PubMed ID: 29518473
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer.
Meng F; Henson R; Wehbe-Janek H; Ghoshal K; Jacob ST; Patel T
Gastroenterology; 2007 Aug; 133(2):647-58. PubMed ID: 17681183
[TBL] [Abstract][Full Text] [Related]
8. A Preliminary Investigation of PVT1 on the Effect and Mechanisms of Hepatocellular Carcinoma: Evidence from Clinical Data, a Meta-Analysis of 840 Cases, and In Vivo Validation.
Zhang Y; Wen DY; Zhang R; Huang JC; Lin P; Ren FH; Wang X; He Y; Yang H; Chen G; Luo DZ
Cell Physiol Biochem; 2018; 47(6):2216-2232. PubMed ID: 29975928
[TBL] [Abstract][Full Text] [Related]
9. [Relationships between microRNA expressions and prognosis in patients with tongue squamous cell carcinoma and the mechanisms microRNA regulating tongue squamous cell carcinoma biological behavior].
Jia LF; Gan YH; Yu GY
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 48(1):5-9. PubMed ID: 26885901
[TBL] [Abstract][Full Text] [Related]
10. The expression and functions of microRNAs in pancreatic adenocarcinoma and hepatocellular carcinoma.
Li W; Lebrun DG; Li M
Chin J Cancer; 2011 Aug; 30(8):540-50. PubMed ID: 21801602
[TBL] [Abstract][Full Text] [Related]
11. Molecular Pathways Leading to Induction of Cell Death and Anti-Proliferative Properties by Tacrolimus and mTOR Inhibitors in Liver Cancer Cells.
Navarro-Villarán E; de la Cruz-Ojeda P; Contreras L; González R; Negrete M; Rodríguez-Hernández MA; Marín-Gómez LM; Álamo-Martínez JM; Calvo A; Gómez-Bravo MA; de la Cruz J; Padillo J; Muntané J
Cell Physiol Biochem; 2020 May; 54(3):457-473. PubMed ID: 32369692
[TBL] [Abstract][Full Text] [Related]
12. Exosomal microRNAs as potential biomarkers for cancer cell migration and prognosis in hepatocellular carcinoma patient-derived cell models.
Yu LX; Zhang BL; Yang Y; Wang MC; Lei GL; Gao Y; Liu H; Xiao CH; Xu JJ; Qin H; Xu XY; Chen ZS; Zhang DD; Li FG; Zhang SG; Liu R
Oncol Rep; 2019 Jan; 41(1):257-269. PubMed ID: 30542726
[TBL] [Abstract][Full Text] [Related]
13. miRNA Signature of Hepatocellular Carcinoma Vascularization: How the Controls Can Influence the Signature.
Fittipaldi S; Vasuri F; Bonora S; Degiovanni A; Santandrea G; Cucchetti A; Gramantieri L; Bolondi L; D'Errico A
Dig Dis Sci; 2017 Sep; 62(9):2397-2407. PubMed ID: 28639131
[TBL] [Abstract][Full Text] [Related]
14. Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis.
Pizzini S; Bisognin A; Mandruzzato S; Biasiolo M; Facciolli A; Perilli L; Rossi E; Esposito G; Rugge M; Pilati P; Mocellin S; Nitti D; Bortoluzzi S; Zanovello P
BMC Genomics; 2013 Aug; 14():589. PubMed ID: 23987127
[TBL] [Abstract][Full Text] [Related]
15. A functional screening identifies five microRNAs controlling glypican-3: role of miR-1271 down-regulation in hepatocellular carcinoma.
Maurel M; Jalvy S; Ladeiro Y; Combe C; Vachet L; Sagliocco F; Bioulac-Sage P; Pitard V; Jacquemin-Sablon H; Zucman-Rossi J; Laloo B; Grosset CF
Hepatology; 2013 Jan; 57(1):195-204. PubMed ID: 22865282
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression of miR-889 forecasts an unfavorable prognosis and facilitates cell progression in hepatocellular carcinoma.
Wang H; Wang H; Cui W; Zhang Q; Li J; Zhang Q
Diagn Pathol; 2021 Jun; 16(1):51. PubMed ID: 34116691
[TBL] [Abstract][Full Text] [Related]
17. The long noncoding RNA
Ren Y; Shang J; Li J; Liu W; Zhang Z; Yuan J; Yang M
J Biol Chem; 2017 Oct; 292(43):17939-17949. PubMed ID: 28887306
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-122 affects cell aggressiveness and apoptosis by targeting PKM2 in human hepatocellular carcinoma.
Xu Q; Zhang M; Tu J; Pang L; Cai W; Liu X
Oncol Rep; 2015 Oct; 34(4):2054-64. PubMed ID: 26252254
[TBL] [Abstract][Full Text] [Related]
19. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation.
Lou W; Chen J; Ding B; Chen D; Zheng H; Jiang D; Xu L; Bao C; Cao G; Fan W
J Transl Med; 2018 Sep; 16(1):266. PubMed ID: 30268144
[TBL] [Abstract][Full Text] [Related]
20. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma.
Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
